Prognostic value of cardiac troponin T elevation is independent of renal function and clinical findings in heart failure patients

Cardiology Journal

Volumn 17, Issue 1, 2010, Pages 42-48

  Orea Tejeda, Arturo ^a   Sánchez González, Luis R ^a   Castillo Martínez, Lilia ^a   Valdespino Trejo, Adrian ^a   Sánchez Santillán, Rocío N ^a   Keirns Davies, Candace ^b   Colín Ramírez, Eloisa ^a   Montańo Hernández, Patricia ^a   Dorantes García, Joel ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Clinical findings; Kidney and heart failure; Troponin elevation

Indexed keywords

ALANINE AMINOTRANSFERASE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ASPARTATE AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LACTATE DEHYDROGENASE; LOOP DIURETIC AGENT; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TROPONIN T;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY COMPOSITION; BODY MASS; CHEMOLUMINESCENCE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART FAILURE; HUMAN; HYPERTENSION; HYPERVOLEMIA; HYPOALBUMINEMIA; IMMUNOASSAY; KIDNEY FUNCTION; KIDNEY INJURY; LACTATE DEHYDROGENASE BLOOD LEVEL; LUNG PRESSURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SYSTOLIC DYSFUNCTION; WATER RETENTION;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD VOLUME; ELECTROCHEMICAL TECHNIQUES; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; HYPERTENSION; IMMUNOASSAY; KIDNEY; LUMINESCENT MEASUREMENTS; LUNG; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PRESSURE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SODIUM POTASSIUM CHLORIDE SYMPORTER INHIBITORS; TROPONIN T;

EID: 75749112517     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jessup M, Brozena S. Heart failure. N Eng J Med, 2003; 348: 2007-2018.
2. McMurray JJV, Pfeffer MA. Heart failure. Lancet, 2005; 365: 1877-1889.
3. Nieminen MS, Bohm M, Cowie MR et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J, 2005; 26: 384-416.
4. Cleland JG, Swedberg K, Follth F et al. The EuroHeart Failure survey program: A survey on the quality of care among patients with heart failure in Europe. Part 1: Patients characteristics and diagnosis. Eur Heart J, 2003; 24: 442-463.
5. Missov E, Mair J. A novel biochemical approach to congestive heart failure: Cardiac troponin T. Am Heart J, 1999; 138: 95-98.
6. Perna ER, Macin SM, Cimbaro CJP et al. Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification. Circulation, 2004; 110: 2376-2382.
7. Sato Y, Kita T, Takatsu Y, Kimura T. Biochemical markers of myocite injury in heart failure. Heart, 2004; 90: 1110-1113.
8. Babuin L, Jaffe AS. Troponin: The biomarker of choice for the detection of cardiac injury. CMAJ, 2005; 173: 1191-1202.
9. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamic, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation, 2003; 108: 833-838.
10. Panteghini M. Role and importance of biochemical markers in clinical cardiology. Eur Heart J, 2004; 25: 1187-1196.
11. Perna ER, Macin SM, Cimbaro CJP et al. High levels of troponin T are associated with ventricular remodeling and adverse in-hospital outcome in heart failure. Med Sci Monit, 2004; 10: 90-95.
12. Sato Y, Taniguchi R, Nagai K et al. Measurements of cardiac troponin T in patients with hypertrophic cardiomyopathy. Heart, 2003; 89: 659-660.
13. Sato Y, Yamada T, Taniguchi R et al. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation, 2001; 103: 369-374.
14. Wang AM, Lam CK, Yu CM et al. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Intern, 2006; 70: 444-452.
15. Freda BJ, Tang WHW, Van Lente F et al. Cardiac troponins in renal insufficiency: Review and clinical implications. J Am Coll Cardiol, 2002; 40: 2065-2071.
16. Piccoli A, Nescolarde LD, Rosell J. Análisis convencionaly vectorial de bioimpedancia en la práctica clínica. Nefrología, 2002; 22: 228-238.
17. Castillo-Martínez L, Colín-Ramírez E, Orea-Tejeda A et al. Bioelectrical impedance and strength measurements in patients with heart failure: Comparison with functional class. Nutrition, 2007; 23: 412-418.
18. Sukova J, Ostadal P, Widimsky P. Profile of patients with acute heart failure and elevated troponin I levels. Exp Clin Cardiol, 2007; 12: 153-156.
19. Perna ER, Macin SM, Ciambaro Canela CO et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Card, 2005; 99: 253-261.
20. La Vecchia L, Mezzena G, Ometto R et al. Detectable serum troponin I in patients with heart failure of nonmyocardial ischemic origin. Am J Cardiol, 1997; 80: 88-90.
21. Nellessen U, Goder S, Schobre R, Abawi M, Hecker H, Tschoke S. Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy. Clin Cardiol, 2006; 29: 219-224.
22. Gangji AS, Al Helal B, Churchill DN, Brimble KS, Margetts PJ. Association between N-terminal propeptide B-type natriuretic peptide and markers of hypervolemia. Peritoneal Dialysis Intern, 2008; 28: 308-311.
23. Aviles RJ, Askari AT, Lindal B et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med, 2002; 346: 2047-2052.
24. Mallamaci F, Zoccali C, Parlongo S et al. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis, 2002; 40: 68-75.
25. Wood GNK, Keevil B, Gupta J et al. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: A 2 year prospective study. Nephrol Dial Transpl, 2003; 18: 1610-1615.
26. De Filippi C, Wasserman S, Rosanio S. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis and cardiomiopathy in patients undergoing long-term hemodialysis. JAMA, 2003; 290: 353-359.
27. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end stage renal disease. Circulation, 2002; 106: 2941-2945.
28. Orea-Tejeda A, Colín-Ramírez E, Hernández-Gilsoul T et al. Microalbuminuria in systolic and diastolic chronic heart failure patients. Cardiol J, 2008; 15: 143-149.
29. van Wolferen SA, Marcus JT, Boonstra A et al. Prognostic value of right ventricular mass, volume and function in idiopathic pulmonary arterial hypertension. Eur Heart J, 2007; 28: 1250-1257.
30. Olivei MC, Sosso E, Ventimiglia KS, Macchiarulo R, Quattrocchio G, Guglielmotti E. Indices of muscular damage in the perioperative period of peripheral revascularization procedures. Minerva Anestesiol, 2004; 70: 793-799.
31. Harrison A, Amundson S. Evaluation and management of the acutely dyspneic patient: The role of biomarkers. Am J Emerg Med, 2005; 23: 371-378.
32. Amman P, Maggiorini M, Bertel O et al. Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes. J Am Coll Cardiol, 2003; 41: 2004-2009.